Allocation Fund: Gmo Benchmark

allocation fund: GMO has usually rebounded, with the 78-year-old investor earning acclaim with asset-bubble calls ahead of Wall Street busts in 2000 and 2008, according to Market Watch. Lately, though, the firm is going through one of its roughest periods. Grantham, co-founder and chief investment strategist of Boston money manager Grantham Mayo Van Otterloo & Co., has been out of step with the market several times during the firm's four decades. Assets under management have tumbled to about 80 billion, according to someone close to the matter, down from a peak of 124 billion in June 2014. Bearish about what it sees as high valuations of U.S. stocks, GMO's flagship mutual fund, the GMO Benchmark Free Allocation fund, has largely missed out on the latest rally in U.S. stock indexes SPX, 0.00%DJIA, -0.16% . An expanded version of this report appears at WSJ. Popular at WSJ Why Apple's critics are right this time Health-law taxes complicate GOP's repeal strategy More from Market Watch Best of CES 2017 Gadgets Galore Bicyclist John Howard's 1985 Land-Speed Record Speed Cyclist Denise Mueller's Record-Setting Run An acting chief executive has been running GMO for more than six months and the firm fired about 10% of its workforce, cutting some 65 jobs, in June last year. (news.financializer.com). As reported in the news.